{"url_path":"/sec/bpth/8-k/2026-07-16/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-16","source_url":"https://www.sec.gov/Archives/edgar/data/1133818/0001663577-26-000218-index.html","accession_number":"0001663577-26-000218","cik":"0001133818","ticker":"BPTH","issuer_name":"BIO-PATH HOLDINGS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1133818/0001663577-26-000218-index.html","primary_entity_key":"0001133818","primary_entity_name":"BIO-PATH HOLDINGS, INC."},"word_count":323,"has_tables":true,"body_markdown":"Bio-Path Holdings, Inc. - Form 8-K - April 30, 2026\n\nfalse\n--12-31\n0001133818\n\n0001133818\n\n2026-04-30\n2026-04-30\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\n** **\n\n**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**WASHINGTON, DC 20549**\n\n \n\n**FORM 8-K**\n\n \n\n**CURRENT REPORT PURSUANT**\n\n**TO SECTION 13 OR 15(d) OF THE**\n\n**SECURITIES EXCHANGE ACT OF 1934**\n\n \n\nDate of report (Date of earliest event\nreported): April 30, 2026\n\n \n\n**BIO-PATH HOLDINGS,\nINC.**\n\n(Exact name of registrant as specified in its charter)\n\n \n\n**Wyoming**\n \n**001-36333**\n \n**87-0652870**\n\n(State or other jurisdiction\n\nof incorporation)\n\n \n(Commission File Number)\n \n(IRS Employer Identification No.)\n\n \n\n \n\n**625 Stanwix St. #2407, Pittsburgh, PA**\n \n**15222**\n\n(Address of principal executive offices)\n \n(Zip Code)\n\n \n\n**(630) 708-0750**\n\n(Registrant’s Telephone Number, Including Area\nCode)\n\n \n\nCheck the appropriate box below if the Form 8-K\nfiling is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:\n\n \n\n☐\nWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)\n\n☐\nSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)\n\n☐\nPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\n☐\nPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))\n\n \n\n \n\nSecurities registered pursuant to Section 12(b)\nof the Act:\n\n \n\nTitle of each class\n \nTrading Symbol\n \nName of each exchange on which registered\n\nCommon Stock, par value $0.001 per share\n \nBPTH\n \nOTC Pink\n\n \n\nIndicate by check mark whether the registrant\nis an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the\nSecurities Exchange Act of 1934 (§240.12b-2 of this chapter).\n\n \n\nEmerging\ngrowth company ☐\n\n \n\nIf\nan emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying\nwith any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\n \n\n 1 \n\n \n\nBio-Path Holdings, Inc. is referred to herein as “Bio-Path”,\n“we”, “us”, or “the Company”."}